RSNN praise the Kingdom’s containment of Corona
Regulatory Science Network Netherlands (RSNN) praised on Sunday the Kingdom’s experience in containing the outbreak of the Coronavirus with efficiency and competence.
It noted the development that the health sector is witnessing, in particular, in the field of vigilance, drug safety, and drug safety monitoring.
It also praised the control over food products, medical devices, and products and assessed their risks.
These praises and positive opinions came during the official visit of the delegation of the Food and Drug Authority to the Kingdom of the Netherlands recently.
Several meetings were held with leading scientific and regulatory bodies; To discuss possible opportunities for cooperation, and to exchange distinguished international experiences and relevant expertise and information.
Through the visit, the authority aims to review the success stories of the Kingdom and the authority, especially in the fields of “food, medicine, devices, medical products, cosmetics, pesticides, and feed.”
It also aims to review the distinguished international experiences in the field of biotechnology, and discuss ways of cooperation in the developmental and organizational fields, to enhance local capabilities and provide the necessary capabilities.
This will contribute to developing the national biotechnology system, and achieving strategic goals in this vital sector in terms of localizing vital industries and pharmaceutical security for vital medicines and vaccines.
During these visits, the “Food and Drug Administration” delegation was briefed on the services provided by each entity in the relevant fields.
The Netherlands National Institute for Public Health and the Environment (RIVM) was visited; The institute owns biopharmaceutical laboratories and a Collaborative Center on Food Safety in collaboration with the World Health Organization (WHO) and the Codex Alimentarius Commission (CODEX).
The Institute also cooperation and coordination with the European Food Safety Authority (EFSA) to standardize food monitoring programs and food consumption research projects.
There is also interest in international cooperation opportunities in the field of medical devices, specifically with the “Global Harmonization of Medical Devices Organization” (GHWP).
The European Medicines Agency (EMA), a decentralized agency of the European Union responsible for scientific evaluation, supervision, and safety control of medicines, was among the most prominent visited.
The delegation visited the Department of Pharmacoepidemiology and Clinical Pharmacology at Utrecht University, which aims to identify areas of development in the health field.
The department contains three vital centers: research methods, clinical treatment, legislation, and drug policy, in cooperation with the World Health Organization.
The delegation members discussed with the department officials the issues of vigilance, drug safety, and drug epidemiology, in addition to drug policies.
The visit included the “Medication Evaluation Board”, which evaluates the quality, efficacy, and safety of the medicines submitted for registration, and also encourages the optimal use of the drug by the patient.
The council makes recommendations to the Ministry of Health – under which it operates – and in turn, it is responsible for implementing decisions such as approving the registration of a product or withdrawing it based on safety reports.
Among the council’s work is the evaluation of veterinary medicinal products through the Unit for Veterinary Medicinal Products and Evaluation of New Foods. It also contributes to the decision-making process of the Veterinary Medicines Council.
Among the scientific bodies visited by the authority’s delegation in the Netherlands was the “Wageningen Research Institute for Food Safety”, which is an international and European reference laboratory.
The Institute contributes to conducting laboratory analyzes for the Dutch Food Safety Authority, conducting independent scientific research through laboratory analysis, conducting scientific research in forensic medicine, and analyzing and evaluating risks.
It also advises government authorities, collects the results of monitoring plans from these laboratories, and then sends them to the European Food Safety Authority (EFSA).
The SFDA delegation aimed to visit the training center in the Leiden Biotechnology Cluster. This gathering provides the appropriate environment for biotechnology-related activities.
The center includes more than 215 organizations represented by 150 specialized companies and many internationally recognized research institutes.